ARPC1B and infection: Since Arpc1B mutations are associated with an increased propensity to develop infections (Kahr et al, 2017; Brigida et al, 2018; Tur-Gracia and Martinez-Quiles, 2021), our findings open up a new therapeutic avenue, involving Arp2/3 complex augmentation, for infectious diseases.